A series of specific task ionic liquids (ILs) based on a pyridiniumhydrazone scaffold in combination with hexafluorophosphate (PF6−), tetrafluoroboron (BF4−) and/or trifluoroacetate (CF3COO−) counter anion, were designed and characterized by IR, NMR and mass spectrometry. The reactions were conducted under both conventional and green ultrasound procedures. The antifungal potential of the synthesized compounds 2–25 was investigated against 40 strains of Candida (four standard and 36 clinical isolates). Minimum inhibitory concentrations (MIC90) of the synthesized compounds were in the range of 62.5–2000 μg/mL for both standard and oral Candida isolates. MIC90 results showed that the synthesized 1-(2-(4-chlorophenyl)-2-oxoethyl)-4-(2-(4-fluorobenzylidene)hydrazinecarbonyl)-pyridin-1-ium hexafluorophosphate (11) was found to be most effective, followed by 4-(2-(4-fluorobenzylidene)hydrazinecarbonyl)-1-(2-(4-nitrophenyl)-2-oxoethyl)-pyridin-1-ium hexafluorophosphate (14) and 1-(2-ethoxy-2-oxoethyl)-4-(2-(4-fluorobenzylidene)hydrazinecarbonyl)pyridin-1-ium hexafluorophosphate (8). All the Candida isolates showed marked sensitivity towards the synthesized compounds. Ergosterol content was drastically reduced by more active synthesized compounds, and agreed well with MIC90 values. Confocal scanning laser microscopy (CLSM) results showed that the red colored fluorescent dye enters the test agent treated cells, which confirms cell wall and cell membrane damage. The microscopy results obtained suggested membrane-located targets for the action of these synthesized compounds. It appears that the test compounds might be interacting with ergosterol in the fungal cell membranes, decreasing the membrane ergosterol content and ultimately leading to membrane disruption as visible in confocal results. The present study indicates that these synthesized compounds show significant antifungal activity against Candida which forms the basis to carry out further in vivo experiments before their clinical use.
The rhizome (root) of turmeric (Curcuma longa) has long been used in traditional Asian medicine to treat various human body disorders. In this study, we have carried out the phytochemical analysis and anticandidal examination of the ethanolic extract of Curcuma longa rhizome. Phytochemical analysis of the test extract revealed the presence of alkaloids, tannins, amino acids, cardiac glycosides, and diterpenes. In GC-MS analysis, the major compound found was aromatic (ar-) tumerone (32.73%). Antifungal activity of the test extract was investigated against fifteen fluconazole-sensitive and five fluconazole-resistant Candida isolates. Minimum inhibitory concentrations (MIC90) ranged from 600 to 2400 µg/ml for both sensitive and resistant strains. Ergosterol content was drastically reduced by the test extract (MIC90), 54.8 % in sensitive and 58.2 % in resistant isolates. The drop in sterol content correlated well with MIC90 values. It appears that the test extract acts in a dose-dependent fashion to decrease the ergosterol content in treated samples. Cellular toxicity of test extract against H9c2 rat cardiac myoblasts was less than 12% at the highest MIC value. These findings encourage further development of ethanolic extract of Curcuma longa rhizome.